EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Melandryoside attenuates steatohepatitis and fibrosis by restoring PPM1A-mediated SMAD signaling termination

Yo Han Lee, Youngsang Nam, Kieun Park, Haneul Ji, Ji Won Kim, Sooyeon Cho, Na Gyeong Kim, Kwangho Kim, Jiwon Yoo, Ji Young Lee, Chang-Hwan Bae, Eunsoo Kim und 6 weitere

Frontiers in Pharmacology · 05.08.2026 · 17

DOI: 10.3389/fphar.2026.1880176 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 05.08.2026. Verfasst von Yo Han Lee und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Ulsan National Institute of Science and Technology (UNIST), Ulsan, Republic of Korea. Die Arbeit nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Metabolic dysfunction-associated steatohepatitis (MASH) is characterized by hepatic steatosis, inflammation, and fibrosis, yet effective pharmacological therapies remain limited. Melandrii Herba, a traditional East Asian medicinal herb used to improve blood circulation and relieve inflammatory disorders, has reported anti-inflammatory activity. However, its therapeutic potential and active constituents in MASH remain unclear.

Purpose

This study investigated the hepatoprotective and anti-fibrotic effects of Melandrii Herba ethanol extract (MHE) and its purified constituent melandryoside in MASH and explored the underlying mechanisms.

Methods

Palmitic acid-challenged HepG2 hepatocytes and TGF-β-stimulated HSC-LX2 cells were used to evaluate metabolic and fibrogenic stress responses. In vivo efficacy was examined in choline-deficient, L-amino acid-defined, high-fat diet (CDAHFD)-fed mice, with MHE administered therapeutically after disease establishment (weeks 8–12) under continued dietary challenge. Interactome analysis, co-immunoprecipitation, and PPM1A loss-of-function approaches were used to investigate the underlying mechanisms.

Results

MHE reduced lipid accumulation and oxidative stress in palmitic acid-treated hepatocytes and suppressed TGF-β-induced hepatic stellate cell activation, fibrogenic gene expression, and SMAD2/3 phosphorylation in HSC-LX2 cells. In CDAHFD-fed mice, oral administration of MHE attenuated hepatic steatosis, inflammatory injury, and collagen deposition. Mechanistically, MHE and melandryoside restored PPM1A-SMAD interaction and reduced SMAD2/3 phosphorylation, whereas PPM1A knockdown diminished their anti-fibrotic effects.

Conclusion

MHE and melandryoside alleviated pathological features of MASH by reducing metabolic stress and suppressing fibrotic signaling. These findings identify melandryoside as a bioactive constituent of Melandrii Herba and suggest that regulation of PPM1A-SMAD signaling may represent a potential therapeutic strategy for MASH.

Schlagwörter

Stichwörter der Autor:innen

MASHMelandrii HerbaPPM1AROS productionSmad2de novo lipogenesisfibrosisinflammation

Autor:innen und Institutionen

  • Department of Biological Sciences, Ulsan National Institute of Science and Technology (UNIST), Ulsan, Republic of Korea.
  • College of Pharmacy and Research Institute for Drug Development, Pusan National University, Busan, Republic of Korea.
  • Herbal Medicine Resources Research Center, Korea Institute of Oriental Medicine, Naju, Jeollanam-do, Republic of Korea.
  • Metabolic Regulation Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, Republic of Korea.
  • College of Veterinary Medicine, Jeonbuk National University, Iksan-si, Jeollanam-do, Republic of Korea.
  • Metadium Therapeutics, Ulsan, Republic of Korea.

Zitieren

APA

Lee, Y. H., Nam, Y., Park, K., Ji, H., Kim, J. W., Cho, S., Kim, N. G., Kim, K., Yoo, J., Lee, J. Y., Bae, C. H., Kim, E., Jang, E. S., Kim, W. K., Yun, H., Lee, S. R., Park, J. H., & Choi, J. H. (2026). Melandryoside attenuates steatohepatitis and fibrosis by restoring PPM1A-mediated SMAD signaling termination. Frontiers in Pharmacology, 17. https://doi.org/10.3389/fphar.2026.1880176

Vancouver

Lee YH, Nam Y, Park K, Ji H, Kim JW, Cho S, et al. Melandryoside attenuates steatohepatitis and fibrosis by restoring PPM1A-mediated SMAD signaling termination. Frontiers in Pharmacology. 2026;17. doi:10.3389/fphar.2026.1880176

BibTeX
@article{Lee2026,
  author = {Lee, Yo Han and Nam, Youngsang and Park, Kieun and Ji, Haneul and Kim, Ji Won and Cho, Sooyeon and Kim, Na Gyeong and Kim, Kwangho and Yoo, Jiwon and Lee, Ji Young and Bae, Chang-Hwan and Kim, Eunsoo and Jang, Eun Seo and Kim, Won Kon and Yun, Hwayoung and Lee, Seoung Rak and Park, Jun Hong and Choi, Jang Hyun},
  title = {Melandryoside attenuates steatohepatitis and fibrosis by restoring PPM1A-mediated SMAD signaling termination},
  journal = {Frontiers in Pharmacology},
  year = {2026},
  volume = {17},
  doi = {10.3389/fphar.2026.1880176}
}
Kostenlos starten →